UPDATE : Tuesday, October 15, 2019
Change in licensing-out contract may be bad sign for Intron Biotechnology
Intron Biotechnology said the conditions for last November’s deal with a mu...
by Jeong Sae-im  |  2019-08-30 14:47
Huons, Prestige Bio to develop biosimilars
Huons said that it plans to enter the biosimilar market by collaborating wi...
by Lee Han-soo  |  2019-08-28 16:05
New way found to heal wounds of autoimmune disease patients
Korean researchers have found a new method to quickly heal the wounds of pa...
by Song Soo-youn  |  2019-08-28 15:19
‘GI Innovation will be small but strong leader of bioindustry’
“GI Innovation, armed with both basic science and development strategy, wil...
by Kim Yun-mi  |  2019-08-27 15:57
Invossa victims, Kolon shareholders demand apology, compensation
After the Korea Exchange’s Corporate Review Committee decided to delist Kol...
by Jeong Sae-im  |  2019-08-27 15:40
Regulator decides to delist Kolon TissueGene
Kolon TissueGene, an affiliate of Kolon Life Science, is on the verge of be...
by Jeong Sae-im  |  2019-08-27 12:15
Medipost’s Pneumostem gets FDA’s fast-track designation
Medipost said that the U.S. Food and Drug Administration has given a fast- ...
by Lee Han-soo  |  2019-08-23 17:51
GenNBio to test transplanting pig’s pancreatic islet into human next year
GenNBio said it would officially enter the market of transplanting organs f...
by Jeong Sae-im  |  2019-08-23 13:53
Japan gives further nod to Celltrion's breast cancer biosimilar
Celltrion Healthcare said that Japan's Ministry of Health, Labour and W...
by Lee Han-soo  |  2019-08-22 16:47
Pharmicell submits new drug application for ovarian cancer treatment
Pharmicell said that it has filed an investigational new drug application t...
by Lee Han-soo  |  2019-08-19 13:10
Stock exchange names Kolon Life Science as administrative issue
Kolon Life Science, once one of the most promising bio-stocks, has been dow...
by Lee Han-soo  |  2019-08-16 16:49
Medipost’s stem cell therapy, cord blood bank show solid growth
Medipost’s stem cell therapy Cartistem for osteoarthritis and umbilical cor...
by Jeong Sae-im  |  2019-08-16 16:18
CHA Biotech wins patent for placenta-derived mesenchymal stem cells
CHA Biotech said that it has obtained a patent for the use of placenta-deri...
by Lee Han-soo  |  2019-08-12 18:24
Samsung BioLogics implants cell-culturing tech
Samsung BioLogics said that it has implanted a new cell-culturing technolog...
by Lee Han-soo  |  2019-08-12 16:05
Injectable hydrogels developed to raise stem cell survival rate
Korean researchers have developed a technology of scaffolding stem cells wi...
by Song Soo-youn  |  2019-08-12 15:18
HLB to seek pre-NDA meeting with FDA for rivoceranib
HLB said it would request for a pre-New Drug Application (NDA) meeting with...
by Jeong Sae-im  |  2019-08-06 15:43
Roche, MSD, AstraZeneca: top 3 risers on NASDAQ biotech
Roche, MSD (Merck in the U.S.), and AstraZeneca achieved the most significa...
by Kim Yun-mi  |  2019-08-06 11:29
Pharmicell submits investigational new drug application for prostate cancer treatment
Pharmicell said that it has filed an investigational new drug application t...
by Lee Han-soo  |  2019-08-05 17:59
Sillajen’s trouble heralds fall of one of most prominent biotech firms
Shares of Sillajen continued to take a nosedive Monday after the biotech fi...
by Lee Han-soo  |  2019-08-05 16:55
SillaJen remains confident about Pexa-Vec’s value, despite trial failure
SillaJen said Pexa-Vec, an oncolytic viral drug, still had significant pote...
by Jeong Sae-im  |  2019-08-05 14:49
Back to Top